Enlibrium Overview
- Year Founded
-
2015

- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Enlibrium General Information
Description
Developer of novel drugs designed to treat a range of different cancers. The company's novel drugs are based on metformin that reduces cancer energy consumption and reestablishes energy balance.
Contact Information
Corporate Office
- San Diego, CA
- United States
Corporate Office
- San Diego, CA
- United States
Enlibrium Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Out of Business | 28-Sep-2018 | Completed | Out of Business | |||
1. Early Stage VC (Series A) | 03-Dec-2015 | Completed | Startup |
Enlibrium Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A |
Enlibrium Patents
Enlibrium Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20170210704-A1 | Deutero-phenformin derivatives | Inactive | 21-Jan-2016 |
Enlibrium FAQs
-
When was Enlibrium founded?
Enlibrium was founded in 2015.
-
Where is Enlibrium headquartered?
Enlibrium is headquartered in San Diego, CA.
-
What industry is Enlibrium in?
Enlibrium’s primary industry is Biotechnology.
-
Is Enlibrium a private or public company?
Enlibrium is a Private company.
-
What is Enlibrium’s current revenue?
The current revenue for Enlibrium is
. -
How much funding has Enlibrium raised over time?
Enlibrium has raised $15M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »